Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Galimberti, Daniela, Schoonenboom, Niki, Scheltens, Philip, Fenoglio, Chiara, Bouwman, Femke, Venturelli, Eliana, Guidi, Ilaria, Blankenstein, Marinus A., Bresolin, Nereo, Scarpini, Elio·2006·Archives of Neurology

DOI 10.1001/archneur.63.4.538

Cited by (289)

Items 101–200 of 289

Dysregulation of C-X-C motif ligand 10 during aging and association with cognitive performance
Steven Bradburn, Jamie Stewart McPhee, Liam Bagley, Michael Adam Carroll, MARK A. SLEVIN, Nasser Al‐Shanti, Yoann Barnouin, Jean‐Yves Hogrel, Mati Pääsuke, Helena Gapeyeva et al. · 2017 · Neurobiology of Aging
Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model
Wirz, Kerstin T.S., Bossers, Koen, Stargardt, Anita, Kamphuis, Willem, Swaab, Dick F., Hol, Elly M., Verhaagen, Joost · 2013 · Neurobiology of Aging
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Alexandra Moreno-García, Alejandra Kun, Miguel Calero, Olga Calero · 2021 · Antioxidants
Systemic inflammatory markers in relation to cognitive function and measures of brain atrophy: a Mendelian randomization study
Jiao Min Luo, Saskia le Cessie, Gerard J. Blauw, Claudio Franceschi, Raymond Noordam, Diana van Heemst · 2022 · GeroScience
An internally controlled peripheral biomarker for Alzheimer’s disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
Tapan K. Khan, Daniel L. Alkon · 2006 · Proceedings of the National Academy of Sciences
Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers
Daniela Galimberti, Rossana Bonsi, Chiara Fenoglio, María Serpente, Sara Cioffi, Giorgio Fumagalli, Andrea Arighi, Laura Ghezzi, Marina Arcaro, Matteo Mercurio et al. · 2015 · Brain Behavior and Immunity
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivo
Rachael M. Clarke, Florence O'Connell, Anthony Lyons, Marina A. Lynch · 2006 · Neuropharmacology
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Christopher Haas · 2012 · Journal of Alzheimer s Disease
Interleukin-8 and interleukin-10, brain volume and microstructure, and the influence of calorie restriction in old rhesus macaques
Auriel A. Willette, Christopher L. Coe, Alex C. Birdsill, Barbara B. Bendlin, Ricki J. Colman, Andrew L. Alexander, David B. Allison, Richard H. Weindruch, Sterling C. Johnson · 2013 · AGE
5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer’s Disease
Zahra Manji, Asheebo Rojas, Wenyi Wang, Raymond J Dingledine, Nicholas H. Varvel, Thota Ganesh · 2019 · Journal of Alzheimer s Disease
Ebola: translational science considerations
Francesco Chiappelli, Andre Bakhordarian, April D. Thames, Angela M Du, Allison L Jan, Melissa Nahcivan, Mia T Nguyen, Nateli Sama, Ercolano Manfrini, Francesco Piva et al. · 2015 · Journal of Translational Medicine
Applying fluid biomarkers to Alzheimer's disease
Henrik Zetterberg · 2017 · American Journal of Physiology-Cell Physiology
Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria
Nana O. Wilson, Wesley Solomon, Leonard M. Anderson, John Patrickson, Sidney Pitts, Vincent Craig Bond, Mingli Liu, Jonathan K. Stiles · 2013 · PLoS ONE
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Anna Rita Zuena, Paola Casolini, Roberta Lattanzi, Daniela Maftei · 2019 · Frontiers in Pharmacology
A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia
Sawsen Ayari, Alexandre Abellard, Marion Carayol, Éric Guedj, Olivier Gavarry · 2023 · Experimental Gerontology
CXCL10/CXCR3 signaling in glia cells differentially affects NMDA‐induced cell death in CA and DG neurons of the mouse hippocampus
Hilmar R. J. van Weering, H. W. G. M. Boddeke, Jonathan Vinet, Nieske Brouwer, Alexander H. De Haas, Nico van Rooijen, Allan Randrup Thomsen, Knut P. H. Biber · 2010 · Hippocampus
Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis
Karahan, Hande, Smith, Daniel C., Kim, Byungwook, Dabin, Luke C., Al-Amin, Md Mamun, Wijeratne, H. R. Sagara, Pennington, Taylor, Viana di Prisco, Gonzalo, McCord, Brianne, Lin, Peter Bor-chian et al. · 2021 · Science Advances
Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array
Katrin Berbaum, Kirubakaran Shanmugam, Grant Stuchbury, Florian Wiede, Heinrich Körner, Gerald W Münch · 2008 · Cytokine
Genetics of Late‐Onset Alzheimer′s Disease: Update from the Alzgene Database and Analysis of Shared Pathways
Paolo Olgiati, Antonis M. Politis, George N. Papadimitriou, Diana De Ronchi, Alessandro Serretti · 2011 · International Journal of Alzheimer s Disease
Chronic CXCL10 alters neuronal properties in rat hippocampal culture
Jungsook Cho, Thomas E. Nelson, Hilda Bajova, Donna L. Gruol · 2009 · Journal of Neuroimmunology
CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: Relevance to Alzheimer’s disease
Ashutosh Ashutosh, Wei Kou, Robin L. Cotter, Kathleen Borgmann, Li Wu, Raisa Persidsky, Namita Sakhuja, Anuja Ghorpade · 2011 · Biochemical and Biophysical Research Communications
Potential neurotoxic activity of diverse molecules released by microglia
Ivan A. Lindhout, Taryn E. Murray, Christy M. Richards, Andis Klegeris · 2021 · Neurochemistry International
Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator
Rajeev Mehla, Shalmali Bivalkar-Mehla, Mitzi Nagarkatti, Ashok Chauhan · 2012 · Journal of Neuroinflammation
Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush
Yonju Ha, Hua Liu, Shuang Zhu, Panpan Yi, Wei Liu, Jared Nathanson, Rakez Kayed, Bradford D. Loucas, Jiaren Sun, Laura J. Frishman et al. · 2016 · American Journal Of Pathology
Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders
Yvonne M. Y. Han, Winnie K. Cheung, Chun Kwok Wong, Sophia L. Sze, Timmy W. S. Cheng, Michael Kin-Chung Yeung, Agnes Sui-Yin Chan · 2017 · Frontiers in Immunology
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease
Joung Wook Lee, Hong Namkoong, Hyun Kee Kim, Sanghee Kim, Dong Whi Hwang, Hae Ri Na, Seon-Ah Ha, Jae-Ryong Kim, Jin Woo Kim · 2007 · BMC Neurology
Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi, Soomin C. Song, Yaron Bram, Constance Q. Zhou, Stephanie Jackvony, Robert E. Schwartz, Robert C. Froemke, Adam L. Orr et al. · 2023 · Science Advances
Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
Federica Angiulli, Elisa Conti, C Zoia, Fulvio Da Re, Ildebrando Marco Appollonio, Carlo Ferrarese, Lucio Tremolizzo · 2021 · Diagnostics
Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment
Kang Soo Lee, Ji Hyung Chung, Kyung Hye Lee, Min‐Jeong Shin, Byoung Hoon Oh, Chang Hyung Hong · 2008 · Immunology Letters
Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson’s Disease
Natália Pessoa Rocha, Paula Luciana Scalzo, Izabela Guimarães Barbosa, Mariana Soares de Souza, Isabela Boechat Morato, Érica Leandro Marciano Vieira, Paulo Pereira Christo, Antônio Lúcio Teixeira, Helton José Reis · 2014 · Parkinson s Disease
Therapeutic Effects of the In Vitro Cultured Human Gut Microbiota as Transplants on Altering Gut Microbiota and Improving Symptoms Associated with Autism Spectrum Disorder
Kainan Chen, Yousi Fu, Yali Wang, Langxing Liao, Hongzhi Xu, Aihui Zhang, Junnan Zhang, Lina Fan, Jianlin Ren, Baishan Fang · 2020 · Microbial Ecology
Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways
Muh-Shi Lin, Kuo-Sheng Hung, Wen‐Ta Chiu, Yu Sun, Shin‐Han Tsai, Jia‐Wei Lin, Yi‐Hsuan Lee · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Biomarkers in Alzheimer's Disease: A Review
Meena Chintamaneni, M. Bhaskar · 2012 · ISRN Pharmacology
Soluble TREM2 and Inflammatory Proteins in Alzheimer’s Disease Cerebrospinal Fluid
Boris‐Stephan Rauchmann, Angélique Sadlon, Robert Perneczky, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Journal of Alzheimer s Disease
Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls
Daniel A. Llano, Jinhe Li, Jeffrey F. Waring, Teresa A. Ellis, Viswanath Devanarayan, David G. Witte, Robert A. Lenz · 2011 · Alzheimer Disease & Associated Disorders
CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease
Júlia Faura, Alejandro Bustamante, Anna Peñalba, Dolors Giralt, Alba Simats, Elena A. Martínez-Sáez, Daniel Andres Alcolea, Juan Fortea, Alberto Lleó, Charlotte Elisabeth Teunissen et al. · 2020 · Journal of Alzheimer s Disease
Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression
Thomas E. Nelson, Christine Hao, Jessica C. Manos, Richard M. Ransohoff, Donna L. Gruol · 2011 · Brain Behavior and Immunity
2′,3′-cAMP, 3′-AMP, 2′-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors
Elizabeth A. Newell, Jennifer L. Exo, Jonathan D. Verrier, Travis C. Jackson, Delbert G. Gillespie, Keri L. Janesko‐Feldman, Patrick Michael Kochanek, Edwin Kerry Jackson · 2014 · Brain Research
Cerebrospinal Fluid Monocyte Chemoattractant Protein‐1 in Alcoholics: Support for a Neuroinflammatory Model of Chronic Alcoholism
John C. Umhau, Melanie L. Schwandt, Matthew G. Solomon, Peixiong Yuan, Allison Carol Nugent, Carlos A. Zarate, Wayne Curtis Drevets, Samuel D. Hall, David Ted George, Markus A Heilig · 2014 · Alcoholism Clinical and Experimental Research
Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer’s disease
Charles Lim, Christine J. Hammond, Susan Tuttle Hingley, Brian Joseph Balin · 2014 · Journal of Neuroinflammation
Resveratrol reduces glutamate‐mediated monocyte chemotactic protein‐1 expression via inhibition of extracellular signal‐regulated kinase 1/2 pathway in rat hippocampal slice cultures
Eun Ok Lee, Hee Ju Park, Jihee Lee Kang, Hye‐Sun Kim, Young Hae Chong · 2009 · Journal of Neurochemistry
Inflammation in Neurodegenerative Disorders: Friend or Foe?
Daniela Galimberti, Chiara Fenoglio, Elio Angelo Scarpini · 2008 · Current Aging Science
Circulating inflammatory markers impact cognitive functions in bipolar depression
Sara Poletti, Mario Gennaro Mazza, Federico Calesella, Benedetta Vai, Cristina Lorenzi, Elena Manfredi, Cristina Colombo, Raffaella Zanardi, Francesco Benedetti · 2021 · Journal of Psychiatric Research
Interaction between Interleukin-8 and Methylenetetrahydrofolate Reductase Genes Modulates Alzheimer’s Disease Risk
Keshen Li, Shengyuan Liu, Songpo Yao, Binyou Wang, Dawei Dai, Lifen Yao · 2009 · Dementia and Geriatric Cognitive Disorders
Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons Against Amyloid-β-Induced Toxicity
Cinzia Severini, Pamela Petrocchi Passeri, M. T. Ciotti, Fulvio Florenzano, Roberta Possenti, Cristina Zona, Anna Di Matteo, Angelo Guglielmotti, Pietro Calissano, Joel S. Pachter et al. · 2013 · Journal of Alzheimer s Disease
Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
Jagan A. Pillai, James Bena, Gürkan Bebek, Lynn M. Bekris, Aaron Bonner‐Jackson, Lei Kou, Akshay Pai, Lauge Sørensen, Mads Neilsen, Stephen M. Rao et al. · 2020 · Annals of Clinical and Translational Neurology
The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells
Jungsook Cho, Donna L. Gruol · 2008 · Journal of Neuroimmunology
Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression
Jennifer G. Bray, Kenneth C. Reyes, Amanda J. Roberts, Richard M. Ransohoff, Donna L. Gruol · 2012 · Neuropharmacology
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
Ernest James Phillips, Thomas, Maguire, Emily · 2021 · Frontiers in Cellular Neuroscience
Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer’s drugs
Anchalee Prasansuklab, Suporn Sukjamnong, Atsadang Theerasri, Valerie Wailin Hu, Tewarit Sarachana, Tewin Tencomnao · 2023 · Scientific Reports
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
Henrik Zetterberg, Kaj Blennow · 2012 · Journal of Alzheimer s Disease
Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects
Hochstrasser, Tanja, Marksteiner, Josef, Defrancesco, Michaela, Deisenhammer, Eberhard A., Kemmler, Georg, Humpel, Christian · 2011 · Dementia and Geriatric Cognitive Disorders Extra
Neuroinflammation and β Amyloid Deposition in Alzheimer's Disease: In vivo Quantification with Molecular Imaging
Caroline Hommet, Karl Mondon, Vincent Camus, Maria João Ribeiro, Émilie Beaufils, Nicolas Arlicot, Philippe Corcia, Marc Paccalin, Frédéric Minier, Thomas Gosselin et al. · 2013 · Dementia and Geriatric Cognitive Disorders
Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase (SHP) 2 and p38 Regulate the Expression of Chemokine CXCL8 in Human Astrocytes
Manmeet K. Mamik, Anuja Ghorpade · 2012 · PLoS ONE
Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells
Tadaatsu Imaizumi, Hidemi Yoshida, Ryo Hayakari, Fei Xing, Lian Y. Wang, Tomoh Matsumiya, Kunikazu Tanji, Shogo Kawaguchi, Manabu Murakami, Hiroshi Tanaka · 2015 · Neuroscience Research
Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer’s Disease
Akio Kimura, Nobuaki Yoshikura, Yuichi Hayashi, Takashi Inuzuka · 2017 · Journal of Alzheimer s Disease
Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins
Donna L. Gruol, Khanh Vo, Jennifer G. Bray · 2014 · Frontiers in Cellular Neuroscience
ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: Possible involvement in CXCL10 expression
Tadaatsu Imaizumi, Akiko Numata, Chikashi Yano, Hidemi Yoshida, Pengfei Meng, Ryo Hayakari, Fei Xing, Lian Wang, Tomoh Matsumiya, Kunikazu Tanji et al. · 2014 · Neuroscience Research
Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
Tomone Nagae, Kiho Araki · 2016 · Journal of Clinical & Cellular Immunology
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease
Aina Bellver‐Sanchís, Qizhi Geng, Gemma Navarro, Pedro Antonio Ávila-López, Júlia Companys‐Alemany, Laura Marsal-García, Raquel Larramona‐Arcas, Lluïsa Miró, Anna Pérez‐Bosque, Daniel Ortuño‐Sahagún et al. · 2024 · Aging and Disease
The central role of CXCL10-CXCR3 signaling in neuroinflammation and neuropathology
Alexandro Angelo Bufi, Julia Di Stefano, Andrea Papait, Antonietta Rosa Silini, Ornella Parolini, Peter Ponsaerts · 2025 · Cytokine & Growth Factor Reviews
Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer’s disease
Eleanor King, John Tiernan O'Brien, Paul C. Donaghy, Christopher M. Morris, Nicola A. Barnett, Kirsty Olsen, Carmen M. Martin-Ruiz, John‐Paul Taylor, Alan J. Thomas · 2019 · International Psychogeriatrics
Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
Suzanne M. de la Monte, Ming Tong, Andrew J. Hapel · 2023 · Biomedicines
Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid.
Joanna L. Richens, Kelly Vere, Roger Light, Daniele Soria, Jonathan M. Garibaldi, A. David Smith, Donald R. Warden, Gordon Keith Wilcock, Nin P.S. Bajaj, Kevin Morgan et al. · 2014 · PubMed Central
The Role of the Innate Immune System in Alzheimer’s Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia
Elisa Ridolfi, Cinzia Barone, Elio Angelo Scarpini, Daniela Galimberti · 2013 · Clinical and Developmental Immunology
Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries
Claudia A. Duran-Aniotz, Paulina Orellana, Tomás León Rodríguez, Fernando Henríquez, Victoria Cabello, María F. Aguirre-Pinto, Tamara Escobedo, Leonel Tadao Takada, Stefanie Danielle Piña‐Escudero, Oscar L. López et al. · 2021 · Frontiers in Neurology
Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice
Julie Vérité, Thierry Janet, Damien Chassaing, Bernard Fauconneau, Hanitriniaina Rabeony, Guylène Page · 2018 · Journal of Neuroinflammation
Neuroinvasion of Toxocara canis- and T. cati-larvae mediates dynamic changes in brain cytokine and chemokine profile
Patrick Waindok, Christina Strübe · 2019 · Journal of Neuroinflammation
Knowledge gaps in Alzheimer's disease immune biomarker research
David Morgan, Michelle M. Mielke · 2021 · Alzheimer s & Dementia
MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells
Tadaatsu Imaizumi, Keishu Murakami, Kasumi Ohta, Hirotaka Seki, Tomoh Matsumiya, Pengfei Meng, Ryo Hayakari, Fei Xing, Tomomi Aizawa‐Yashiro, Tetsuya Tatsuta et al. · 2013 · Neuroscience Research
Preventive immunization of aged and juvenile non-human primates to beta-amyloid
Julia Kofler, Brian J. Lopresti, Christopher Janssen, Anita M. Trichel, Eliezer Masliah, Olivera J. Finn, Russell D. Salter, GEOFFREY H. MURDOCH, Chester A. Mathis, Clayton A. Wiley · 2012 · Journal of Neuroinflammation
Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study
Makrina Daniilidou, Jasper Holleman, Göran Hagman, Ingemar Kåreholt, Malin Aspö, Ann Brinkmalm, Henrik Zetterberg, Kaj Blennow, Alina Solomon, Miia Kivipelto et al. · 2024 · Translational Psychiatry
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients
April Denise Thames, Marisa S. Briones, Larry I. Magpantay, Otoniel Martı́nez-Maza, Elyse J. Singer, Charles H. Hinkin, Susan Morgello, Benjamin B. Gelman, David J. Moore, Keith G. Heinzerling et al. · 2015 · AIDS
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
Roberta Lattanzi, Daniela Maftei, Carla Petrella, Massimo Pieri, Giulia Maria Sancesario, Tommaso Schirinzi, Sergio Bernardini, Christian Barbato, Massimo Ralli, Antonio Greco et al. · 2019 · Cells
Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease
Christoffer Rosén, Henrik Zetterberg · 2013 · Current Opinion in Psychiatry
IP‐10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease
Daniela Galimberti, Eliana Venturelli, Chiara Fenoglio, Carlo Lovati, Ilaria Guidi, Diego Scalabrini, Claudio Bruno Mariani, Nereo Bresolin, Elio Angelo Scarpini · 2007 · European Journal of Neurology
Insight into the Molecular Imaging of Alzheimer’s Disease
Abishek Arora, Neeta Bhagat · 2016 · International Journal of Biomedical Imaging
Cytokine Gene Polymorphisms Associated With Symptom Clusters in Oncology Patients Undergoing Radiation Therapy
Christine A. Miaskowski, Yvette P. Conley, Judy Mastick, S M Paul, Bruce A. Cooper, Jon D. Levine, Mitchell R. Knisely, Kord M. Kober · 2017 · Journal of Pain and Symptom Management
The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies
Karahan, Hande, Smith, Daniel C., Kim, Byungwook, McCord, Brianne, Mantor, Jordan, John, Sutha K., Al-Amin, Md Mamun, Dabin, Luke C., Kim, Jungsu · 2023 · Frontiers in Immunology
Investigating interleukin-8 in Alzheimer's disease: A comprehensive review
Delia Righi, Carlo Manco, Matteo Pardini, Angela Stufano, Valentina Schino, Virginia Pelagotti, Federico Massa, Nicola De Stefano, Domenico Plantone · 2024 · Journal of Alzheimer s Disease
Characterisation of amyloid-induced inflammatory responses in the rat retina
David R Howlett, Simon T. Bate, S. Collier, Amanda J. Lawman, Trevor D. Chapman, Tracey E. Ashmeade, Ian C. B. Marshall, Peter J. Anderson, Karen L. Philpott, Jill C. Richardson et al. · 2011 · Experimental Brain Research
Negative regulation of IL-8 in human astrocytes depends on β-catenin while positive regulation is mediated by TCFs/LEF/ATF2 interaction
KaReisha F. Robinson, Srinivas D. Narasipura, Jennillee Wallace, Ethan Matthew Ritz, Lena Al‐Harthi · 2020 · Cytokine
CSF in Alzheimer's Disease
Henrik Zetterberg, Ronald Lautner, Tobias Borgh Skillbäck, Christoffer Rosén, Pashtun Shahim, Niklas Mattsson, Kaj Blennow · 2014 · Advances in clinical chemistry
Clinical phenotypes and genetic biomarkers of FTLD
Daniela Galimberti, Elio Angelo Scarpini · 2012 · Journal of Neural Transmission
Interleukin-8 gene polymorphism –251T>A contributes to Alzheimer's disease susceptibility
Biyong Qin, Li Li, Shanshan Wang, Jun Wu, Yulan Huang, Ping Zhou, Jiao Bai, Yan Zheng · 2016 · Medicine
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
Ester Esteban‐De Antonio, Maitée Rosende‐Roca, Alba Pérez‐Cordón, Silvia Gil, Adelina Orellana, Amanda C. Cano, Montserrat Alegret, Ana Espinosa, Emilio Alarcón‐Martín, Sergi Valero et al. · 2021 · Journal of Alzheimer s Disease
The "Alzheimer's disease signature": potential perspectives for novel biomarkers
Sergio Davinelli, Mariano Intrieri, Claudio Russo, Alfonso Di Costanzo, Davide Zella, Paolo Bosco, Giovanni Scapagnini · 2011 · Immunity & Ageing
Interleukin-8-251T > a, interleukin-1α-889C > t and apolipoprotein e polymorphisms in Alzheimer's disease
Alex Augusto Vendramini, Roger Willian de Lábio, Lucas Trevizani Rasmussen, Nathali Mattiuzo dos Reis, Thaı́s Minett, Paulo Henrique Ferreira Bertolucci, Marcela Augusta de Souza Pinhel, Dorotéia Rossi Silva Souza, Diego R. Mazzotti, Marı́lia de Arruda Cardoso Smith et al. · 2010 · Genetics and Molecular Biology
Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases
Ann Brinkmalm, Erik Portelius, Gunnar Brinkmalm, Josef Pannee, Rahil Dahlén, Johan Gobom, Kaj Blennow, Henrik Zetterberg · 2018 · Journal of Neurochemistry
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, Per, Almqvist, Erik G., Wallin, Anders, Johansson, Jan-Ove, Andreasson, Ulf, Blennow, Kaj, Zetterberg, Henrik, Svensson, Johan · 2017 · PLOS ONE
Role of chemokines in aging and age-related diseases
Jitendra Kumar Chaudhary, Ajay Kumar Danga, Anita Kumari, Akshay Bhardwaj, Pramod C. Rath · 2024 · Mechanisms of Ageing and Development
Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition
Lisi Flores Aguilar, M. Florencia Iulita, Chiara Orciani, Neil Tanna, Jingyun Yang, David Alan Bennett, A. Claudio Cuello · 2021 · Journal of Neuroinflammation
MCP-1 A-2518G Polymorphism: Effect on Susceptibility for Frontotemporal Lobar Degeneration and on Cerebrospinal Fluid MCP-1 Levels
Daniela Galimberti, Eliana Venturelli, Chiara Villa, Chiara Fenoglio, Francesca Clerici, Alessandra Marcone, Luisa Benussi, Francesca Cortini, Diego Scalabrini, Luca Perini et al. · 2009 · Journal of Alzheimer s Disease
Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus–myoclonus syndrome
Michael R. Pranzatelli, E. Tate, Nathan R. McGee, Anna L. Travelstead, S J Verhulst, Richard M. Ransohoff · 2013 · Clinical & Experimental Immunology
Blocking CXCR3 with AMG487 ameliorates the blood-retinal barrier disruption in diabetic mice through anti-oxidative
Honggang Wang, Jian‐Mei Li, Peiyu Zhong, Shuaiwei Wang, Lei Zhang, Ruisheng Yang, Dongdong Wu, Mingliang Chen, Ailing Ji, Yanzhang Li et al. · 2019 · Life Sciences
Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-κB in hippocampal neuronal cell culture
Hilda Bajova, Thomas E. Nelson, Donna L. Gruol · 2008 · Journal of Neuroimmunology
Brain interleukins and Alzheimer’s disease
Heba G. Abdelhamed, Arwa A. Hassan, Alaa Sakraan, Radwa T. Al-Deeb, Dalia M. Mousa, Heba S. Aboul Ezz, Neveen A. Noor, Yasser A. Khadrawy, Nasr M. Radwan · 2025 · Metabolic Brain Disease
Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies
Ruqaiya Jamal, Mohammad Abuzar Shaikh, Mohamad Taleuzzaman, Ziyaul Haque, Mohammed Albratty, Md Shamsher Alam, Hafiz Antar Makeen, Khalid A. Zoghebi, Safaa Fathy Saleh · 2025 · Journal of Alzheimer s Disease
Differential chemokine alteration in the variants of primary progressive aphasia—a role for neuroinflammation
Aitana Sogorb‐Esteve, Imogen J. Swift, Ione Woollacott, Jason D. Warren, Henrik Zetterberg, Jonathan Daniel Rohrer · 2021 · Journal of Neuroinflammation
A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer’s Disease
Fatima El Idrissi, Bernard Gressier, David Devos, Karim Bélarbi · 2021 · Frontiers in Pharmacology